Page last updated: 2024-08-21

pyrazines and deoxyglucose

pyrazines has been researched along with deoxyglucose in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19903 (23.08)18.7374
1990's5 (38.46)18.2507
2000's0 (0.00)29.6817
2010's4 (30.77)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Essig, A; Hong, CD1
Cornford, EM1
Grome, JJ; Harper, AM1
Fazio, F; Landoni, C; Lucignani, G; Monti, LD; Moresco, RM; Piatti, P; Pozza, G; Stefani, I1
Bergman, J; Haaparanta, M; Härkönen, R; Hartiala, J; Knuuti, MJ; Mäki, M; Nuutila, P; Ruotsalainen, U; Teräs, M; Voipio-Pulkki, LM; Wegelius, U; Yki-Järvinen, H1
Bax, JJ; Cornel, JH; Heine, RJ; van Lingen, A; Veening, MA; Visser, CA; Visser, FC1
Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Valkema, R; van Lingen, A; Visser, FC1
Gasser, R; Grisold, M; Köppel, H1
Kishimoto, M; Noda, M1
Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K1
Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S1
Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S1
Kulkarni, P; Padmanabhan, S1

Reviews

1 review(s) available for pyrazines and deoxyglucose

ArticleYear
FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.
    European heart journal, 1997, Volume: 18 Suppl D

    Topics: Cardiotonic Agents; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Predictive Value of Tests; Pyrazines; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1997

Trials

4 trial(s) available for pyrazines and deoxyglucose

ArticleYear
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
    Diabetes, 1995, Volume: 44, Issue:5

    Topics: Adult; Biological Transport, Active; Deoxyglucose; Diabetes Mellitus, Type 1; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Hypolipidemic Agents; Insulin; Male; Myocardium; Pyrazines; Somatostatin; Tomography, Emission-Computed

1995
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
    Cardiovascular diabetology, 2012, Aug-06, Volume: 11

    Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin

2012
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
    Endocrine journal, 2013, Volume: 60, Issue:10

    Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles

2013
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:17

    Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles

2013

Other Studies

8 other study(ies) available for pyrazines and deoxyglucose

ArticleYear
Effects of 2-deoxy-D-glucose, amiloride, vasopressin, and ouabain on active conductance and ENa in the toad bladder.
    The Journal of membrane biology, 1976, Aug-26, Volume: 28, Issue:2-3

    Topics: Amiloride; Animals; Biological Transport, Active; Bufo marinus; Deoxy Sugars; Deoxyglucose; Female; Membrane Potentials; Ouabain; Pyrazines; Sodium; Urinary Bladder; Vasopressins

1976
Oltipraz-induced reduction in schistosomal glucose utilization rates.
    The American journal of tropical medicine and hygiene, 1988, Volume: 38, Issue:2

    Topics: Animals; Deoxyglucose; Female; Glucose; Male; Phosphorylation; Pyrazines; Schistosoma mansoni; Schistosomicides; Thiones; Thiophenes

1988
Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
    Journal of neurochemistry, 1986, Volume: 46, Issue:1

    Topics: Animals; Autoradiography; Behavior, Animal; Brain; Deoxyglucose; Glucose; Guinea Pigs; Lysergic Acid Diethylamide; Male; Methoxydimethyltryptamines; Pyrazines; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin

1986
Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:6

    Topics: Adult; Aged; Coronary Angiography; Deoxyglucose; Diabetes Mellitus, Type 2; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicotinic Acids; Pyrazines; Radionuclide Ventriculography; Tomography, Emission-Computed

1994
Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
    European journal of nuclear medicine, 1997, Volume: 24, Issue:1

    Topics: Aged; Blood Glucose; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Glucose Tolerance Test; Heart; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Tomography, Emission-Computed, Single-Photon

1997
First description of the effect of a non-sulfonylurea compound, tetramethylpyrazine, on coronary response to desoxyglucose-induced ischemia.
    Acta medica Austriaca, 1998, Volume: 25, Issue:1

    Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Deoxyglucose; Flavoring Agents; Guinea Pigs; Myocardial Ischemia; Organ Culture Techniques; Perfusion; Potassium Channels; Pyrazines; Sweetening Agents; Vasodilation

1998
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
    Cardiovascular diabetology, 2011, Dec-22, Volume: 10

    Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles

2011
A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy D glucose in treating COVID-19.
    Biotechnology letters, 2022, Volume: 44, Issue:7

    Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Cytidine; Deoxyglucose; Hexokinase; Humans; Hydroxylamines; Molecular Docking Simulation; Pyrazines; SARS-CoV-2

2022